Inventor
HESSION CATHERINE
US14 patents
⚠️ This page may combine multiple inventors who share the name “HESSION CATHERINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN INC
7 patentsUS6861509B1Mar 1, 2005
Antibodies to Ret and RetL3
BIOGEN INC43 citations94
US6664385B1Dec 16, 2003
Kidney injury-related molecules
BIOGEN INC88 citations94
US6323027B1Nov 27, 2001
Common gamma chain monoclonal antibody blocking agents
BIOGEN INC39 citations92
US4956281ASep 11, 1990
DNA sequences, recombinant DNA molecules and processes for producing lymphocyte function associated antigen-3
BIOGEN INC108 citations92
US6677135B1Jan 13, 2004
Ret ligand (RetL) for stimulating neutral and renal growth
BIOGEN INC30 citations91
US5185441AFeb 9, 1993
Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3
BIOGEN INC16 citations82
US5354665AOct 11, 1994
Recombinant DNA processes for producing PI-linked lymphocyte function associated antigen-3
BIOGEN INC2 citations62
BIOGEN IDEC INC
4 patentsUS7838639B2Nov 23, 2010
Antibodies to train R: a cysteine-rich member of the TNF-receptor family, and methods of treating tumors expressing said receptor
BIOGEN IDEC INC22 citations92
US6770745B2Aug 3, 2004
Common gamma chain blocking agents
BIOGEN IDEC INC24 citations92
US7968680B2Jun 28, 2011
Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby
BIOGEN IDEC INC4 citations60
US7402658B2Jul 22, 2008
TRAIN-R: a cysteine-rich member of the TNF-receptor family
BIOGEN IDEC INC0 citations51